In a recent interview with ILCN, Dr. Karen Reckamp discussed the overall survival implications from the phase II Lung-MAP study and how the phase III follow-up Pragmatica-Lung trial aims to confirm that specific endpoint. Read more
Honorees Drs. Isabelle Opitz, Yuko Nakayama, and Stephen Liu will each give state-of-the-art award lectures tomorrow afternoon, Monday, August 8, during WCLC 2022. Read more
By Joy Curzio Posted: August 21, 2020 The Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer (IASLC), has a 2019 […] Read more
By José Francisco Corona-Cruz, MD We are living in an uncertain world in which the impact, timeline, and duration of the COVID-19 pandemic remain mostly unknown. This has led to […] Read more
By Tetsuya Mitsudomi, MD Posted: April 16, 2020 The general principle of surgery for cancer of any organ is to remove the entire tumor with adequate margins of normal tissue […] Read more
By Leah Lawrence Posted: June 24, 2020 In late February 2020, the U.S. Food and Drug Administration (FDA), American Association for Cancer Research (AACR), and the IASLC held its FDA/CDER-AACR-IASLC […] Read more
By Mariano Provencio, MD, PhD Posted: June 24, 2020 Data can help inform change to standard of care, but at what point do we say enough data is enough and […] Read more
By Leah Lawrence Posted: June 24, 2020 As part of its declaration on tobacco cessation after cancer diagnosis, the IASLC recommended that smoking status, both initially and during the study, […] Read more
By Marina Chiara Garassino, MD, and Leora Horn, MD, MSc, FRCPC Posted: June 9, 2020 Marina Chiara Garassino Leora Horn The new SARS-CoV-2 (COVID-19) virus […] Read more
Please join #LCSM Chat Thursday, June 4, 2020, at 8 pm Eastern time (5 pm Pacific) to discuss the ASCO 2020 Annual Virtual Meeting presentations related to lung cancer. Usually, the ASCO […] Read more